The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit future shots to older Americans and people at higher risk of serious Covid-19 infection.

SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the “Company”), comments on the new COVID Vaccine policy adopted by the US FDA. The new FDA COVID Vaccine Booster Shots policy [1] is based on the findings that the groups that benefit from repeat

When you buy through links on our articles, Future and its syndication partners may earn a commission.

Regulators will require more data showing the shots are safe and effective for healthy adults and children, by requiring randomized, controlled trials to show benefits outweigh risks, FDA Commissioner Marty Makary and Prasad wrote in a commentary in the New England Journal of Medicine.

Almost immediately after former US president Joe Biden's office announced he had been diagnosed with an aggressive prostate cancer, anti-vaccine advocates were blaming his condition on the Covid-19 jabs he publicly received and championed.

As the Trump administration’s FDA moves to limit approval for COVID-19 booster shots, millions of Americans under 65 may find themselves without access this fall. However, until Friday, there’s still time to influence this decision, pro or con, through the FDA’s public comment portal.

U.S. health officials knew about the risks of myocarditis from COVID-19 vaccines but downplayed the concern and delayed informing the public about the risks of taking the jab—that is according to a new Senate report released by GOP Sen.

Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine candidate to wait for efficacy data from a late-stage trial of its influenza shot,